The global laboratory information management system market size was estimated at USD 2.44 billion in 2024 and is projected to reach USD 3.56 billion by 2030, growing at a CAGR of 6.22% from 2025 to 2030. Technological advancements pertinent to pharmaceutical laboratories and a rise in demand for lab automation are expected to fuel the demand for these systems in the coming years.
Advancements in R&D labs, especially in pharmaceutical and biotechnological laboratories, are anticipated to impact the industry positively. In addition, low cost of implementation, efficient time management, and compliance with GDP, GCP & GMP are other major factors driving laboratory information management system industry growth.
The rapid pace of technological innovation in pharmaceutical laboratories is significantly driving the adoption of Laboratory Information Management Systems (LIMS). Pharmaceutical research requires the handling and analyzing of large datasets generated through high-throughput screening (HTS), next-generation sequencing (NGS), mass spectrometry, and other sophisticated analytical techniques. These advancements demand digital tools capable of managing complex workflows, ensuring data integrity, and facilitating regulatory compliance.
Moreover, industries such as pharmaceuticals, biotechnology, and food & beverage are subject to stringent regulations (e.g., FDA, ISO 17025). LIMS solutions help organizations maintain compliance by ensuring data accuracy, traceability, and audit readiness. The need to streamline laboratory workflows, reduce manual errors, and increase throughput has led to the adoption of LIMS. For instance, in April 2025, AstraZeneca implemented Sapio Sciences' LIMS to track trends, identify bottlenecks, and anticipate risks, thereby reducing manual errors and enhancing productivity.
AstraZeneca, a global pharmaceutical company, faced significant challenges in managing the vast and complex data generated by its research and development (R&D) operations. With the increasing drug discovery and development costs, AstraZeneca decided to develop an integrated digital ecosystem by implementing advanced LIMS platforms to streamline data management, enhance efficiency, and accelerate the development of critical therapies.
Furthermore, LIMS platforms are evolving to integrate artificial intelligence (AI), machine learning (ML), and cloud-based infrastructure, offering real-time data access, automated decision-making, and enhanced scalability. For instance, in October 2024, Xybion launched Pristima Web 10.0, a new and enhanced AI-powered web-based SaaS platform designed to optimize preclinical research. This version includes advanced features that facilitate the creation of effective protocols and integrates various lab execution needs into a single, unified system.
"With Pristima Web 10.0, we are setting a new industry standard in preclinical LIMS, while directly addressing laboratories that are struggling with severe limitations and inefficiencies found in other LIMS systems. We've taken the approach of putting the laboratory scientists first by working directly with them when designing the intelligent array of features found in Pristima Web 10.0.”
-Dr. Pradip Banerjee, Chairman and CEO of Xybion.
LIMS has evolved at a rapid pace since its development in the early 1980s. LIMS was initially developed as an in-house project. It then evolved into custom-built solutions, and consequently into open-source LIMS.
The first-generation LIMS systems had automated reporting features. The need for application-specific features emerged with advancements in technology and changes in workflow.
This paved the way for the development of second-generation LIMS, which used commercial relational databases from third parties.
The first on-premise configuration was developed in the early 1990s, using a PC integrated with the security of a minicomputer.
Fourth-generation LIMS systems with the capability of distributing client/server functions over a network were developed in the mid-1990s. The first web-enabled and wireless computing features were integrated into LIMS in 1996.
Present-day LIMS systems offer full functionality to laboratories, helping increase their productivity. These systems are being increasingly used in various sectors, such as agriculture, food & beverage, product quality assessment, environment & water, manufacturing, and cyber forensic analysis.
It is anticipated that LIMS and e-Notebook will be integrated with instruments so as to be combined into a single platform over the forecast period.
The unified platform, along with technologies such as data migration, business intelligence, and data warehousing, is expected to increase the integration of laboratory informatics into enterprises.
The chart below illustrates the relationship between market concentration, industry characteristics, and industry participants. The x-axis represents the level of industry concentration, ranging from low to high. The y-axis represents various industry characteristics, including industry competition, impact of regulations, level of partnerships & collaborations activities, degree of innovation, and regional expansion. For instance, the laboratory information management system industry is fragmented, with many service providers entering the market. The degree of innovation is high, and the level of mergers & acquisitions activities is moderate. The impact of regulations on the industry and the regional expansion is high.
The degree of innovation in the industry is high. The market is experiencing significant innovation as numerous providers introduce new products to meet demand for scientific data integration solutions in various industries. For instance, in March 2025, LabVantage Solutions launched version 8.9 of its leading LIMS platform, designed to enhance laboratory efficiency and data management. This update introduces new features and improvements to accelerate efficiency and speed, improve usability and automation, automate regulatory compliance and data management processes, and streamline and manage complex workflows.
“The 8.9 upgrades not only empower every member of the lab and enhance productivity but also strengthen our platform’s data management efficiencies-an essential foundation for the next generation of SaaS solutions with embedded AI agents.”
-Mikael Hagstroem, CEO of LabVantage Solutions
The level of mergers & acquisitions in the industry is moderate due to a rise in the acquisition of emerging players by major players to increase their capabilities, expand product portfolios, and improve competencies.
The impact of regulations on the market is high. The primary objective of a laboratory is to ensure the generation of high-quality and reliable experimental data that complies with the industry's regulatory guidelines. The combination of technological advancements, stringent regulatory needs, and increasing commercial pressures has resulted in the rapid generation of vast amounts of data from various aspects, including research and development, quality assurance, and manufacturing. This is creating significant challenges for data management processes and conventional documentation requirements, particularly in regulated environments such as the life sciences sector.
The level of regional expansion in the industry is high due to increasing demand for laboratory information management system solutions in developing countries. For instance, in October 2022, Revol successfully implemented its no-code Laboratory Information Management System (LIMS) platform, Revol LIMS 5.0, in various projects across India and the Gulf Cooperation Council (GCC). This web-based solution aims to enhance laboratory management efficiency and streamline operations.
Based on deployment mode, the cloud-based segment led the market with the largest revenue share of 43.61% in 2024 and is expected to grow at the fastest CAGR during the forecast period. Cloud-based deployment enables access to data from multiple access points. In a rapidly expanding remote work culture, the flexibility provided by features like virtual access points is a crucial factor contributing to the dominance of the cloud-based product segment. Furthermore, the reduction of the IT workforce, along with cost-effective data management and streamlined deployment processes, are additional factors that positively influence the growth of this segment.
The web-based segment is anticipated to grow at a significant CAGR over the forecast period, owing to the high adoption of web-hosted LIMS among consumers. These LIMS solutions are suitable for various laboratories, including R&D departments, manufacturing companies, public utilities, and environmental, chemical, contract, and QC labs.
Based on component, the services segment led the market with the largest revenue share of 58.50% in 2024 and is projected to grow at the fastest CAGR from 2025 to 2030. This is due to an increase in the need for LIMS implementation, integration, maintenance, validation, and support. Moreover, high demand for LIMS outsourcing solutions is expected to drive segment growth. Large pharmaceutical research labs often witness a lack of resources and skills required for the deployment of analytics. Thus, these services are outsourced. This outsource is likely to involve short-term, project-based, or long-term contracts. These services are offered in the form of packages, and these packages include compliance with promotional spending, social media analytics, predictive analytics for medical device failure, benchmarking services, and others.
Based on end use, the life science companies segment led the market with the largest revenue share of 40.74% in 2024. This is owing to the high adoption of LIMS in pharmaceutical, biopharmaceutical, and biotechnology companies. Lack of skilled staff, demand for higher productivity, cost efficiency, and increasing demand for biobanks and biorepositories are expected to bolster the growth of this segment.
The contract research organizations (CROs) segment is expected to register at the fastest CAGR from 2025 to 2030. This rapid growth can be attributed to the increase in demand for outsourcing by pharmaceutical and biotechnological companies. Various associated advantages, such as cost efficiency, a necessity to maintain focus on core competencies, and mutual benefits to both contractor and client, are anticipated to drive segment growth over the forecast period.
North America dominated the laboratory information management system market with the largest revenue share of 44.00% in 2024. An increase in the number of biobanks and biorepositories has fueled the need for LIMS, thus propelling its adoption over the years. Moreover, the presence of established pharmaceutical companies & research laboratories and higher awareness about LIMS among end users are expected to drive its demand in the region.
The laboratory information management system market in the U.S.accounted for the largest market revenue share in North America in 2024, due to technology advancements, regulatory demands, and complex operations. In addition, growing demand for LIMS in genomic and cancer research studies is further expected to drive this market in the country. For instance, in October 2024, the Ellison Institute of Technology, Los Angeles (EIT Los Angeles) deployed Sapio Sciences’ LIMS platform to accelerate cancer research and streamline its complex research operations.
The laboratory information management system market in Europe is anticipated to grow at a significant CAGR over the forecast period. Increasing adoption of LIMS to meet regulatory requirements, a growing need for automation, and technological advancements are key factors propelling market growth. Companies are partnering with research centers to provide LIMS, enhancing operational efficiency and accelerating patient treatment advancements. For instance, in June 2021, IQVIA collaborated to provide LIMS to the National Genome Center in Denmark, supporting the center in managing patient genomes.
The UK laboratory information management system market is expected to grow at a significant CAGR over the forecast period, owing to increasing government funding, robust investments in the life science industry, and rising demand for laboratory automation. For instance, in September 2021, the Health Minister launched a new USD 51.56 million LIMS system aimed at enhancing diagnostic services across the country.
The laboratory information management system market in Germany accounted for the largest market revenue share in Europe in 2024, owing to the increasing laboratory automation, digitalization of laboratory data, and stringent regulations across industries. Moreover, the growing mergers, acquisitions, partnerships, and collaborations among key players to expanding capabilities and market reach. For instance, in September 2024, LabVantage Solutions partnered with Henkel to create a new integrated LIMS platform to accelerate digital transformation in research and development.
The laboratory information management system market in Asia Pacific is expected to witness at the fastest CAGR over the forecast period, owing to the rising demand from pharmaceutical manufacturers seeking to improve efficiency and reduce costs. Increasing investments in R&D, especially in pharmaceutical and biotechnology industries, CROs & CDMOs, and a growing focus on laboratory automation are boosting the need for outsourcing, thus creating growth opportunities in the market.
The China laboratory information management system market held the largest share in 2024. Increasing research and development in life sciences, robust presence of life science companies, and technological advancements are key factors contributing to market growth.
The laboratory information management system market in India is expected to grow at a significant CAGR over the forecast period. This growth is driven by the increasing demand for outsourcing and laboratory automation. In addition, India is considered as pharmacy of the world owing to the robust presence of pharmaceutical and biopharmaceutical companies, thereby contributing to market growth.
The laboratory information management system market in Latin America is anticipated to grow at a significant CAGR during the forecast period, due to increasing investments in healthcare infrastructure, growing focus on laboratory automation, and increasing research and development.
The laboratory information management system market in the Middle East & Africa is expected to grow at a significant CAGR over the forecast period. This growth can be attributed to the rising adoption of cloud-based solutions, stringent regulatory requirements, and technological advancements.
The market is highly fragmented, with many small and large players operating in this space. This leads to intense competition between smaller players to sustain their position. Strategies such as new product launches and partnerships are playing a key role in propelling the market growth.
The following are the leading companies in the laboratory information management system market. These companies collectively hold the largest market share and dictate industry trends.
In March 2024, Genseq integrated the Sapio LIMS platform to enhance its next-generation sequencing services. This partnership aims to optimize laboratory operations and improve data management, enabling Genseq to deliver high-quality sequencing results efficiently.
“Because we provide cutting-edge sequencing services, it was important to us to find a modern LIMS that could support our workflows end-to-end without requiring extensive and time-consuming customization,”
-Patrick Buckley, Chief Scientific Officer, at Genseq
“The Sapio platform enables us to carry out consistent, reproducible work and automates key tasks so that our scientists can focus on delivering the best results possible to our clients as quickly as possible.”
In July 2023, LIMS Wizards partnered with LabTwin to introduce LabTwin's innovative voice-activated digital lab assistant to the North American market.
In December 2022, LabVantage Solutions, Inc. released Version 8.8 of its flagship LIMS platform, which features a multitude of upgrades across all components. These factors are expected to boost the growth of the market over the forecast period.
“LabVantage 8.8 exemplifies our dual commitment to both major upgrades to our flagship LIMS platform and continuous improvements, with the goal of providing our customers with an ever easier, safer, smarter, more flexible and more reliable system that enables the digital transformation of their laboratory,”
-Mikael Hagstroem, Chief Executive Officer at LabVantage Solutions.
Report Attribute |
Details |
Market size value in 2025 |
USD 2.63 billion |
Revenue forecast in 2030 |
USD 3.56 billion |
Growth rate |
CAGR of 6.22% from 2025 to 2030 |
Base year for estimation |
2024 |
Historical data |
2018 - 2023 |
Forecast period |
2025 - 2030 |
Quantitative units |
Revenue in USD million/billion and CAGR from 2025 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Deployment mode, component, end use, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S.; Canada; Mexico; Germany; UK; France; Italy; Spain; Norway; Denmark; Sweden; China; Japan; India; South Korea; Australia; Thailand; Brazil; Argentina; Saudi Arabia; South Africa; UAE; and Kuwait |
Key companies profiled |
Thermo Fisher Scientific Inc.; Siemens; LabVantage Solutions Inc.; LabWare; PerkinElmer Inc.; Abbott; Autoscribe Informatics; Illumina, Inc.; Labworks; LabLynx, Inc.; Computing Solutions, Inc.; CloudLIMS.com (LabSoft LIMS); Ovation; LABTRACK; AssayNet Inc. |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global laboratory information management system market report based on deployment mode, component, end use, and region:
Deployment Mode Outlook (Revenue, USD Million, 2018 - 2030)
Web-based
On-premise
Cloud-based
Component Outlook (Revenue, USD Million, 2018 - 2030)
Software
Services
End Use Outlook (Revenue, USD Million, 2018 - 2030)
Life Sciences
CROs
Chemical Industry
Food & Beverage and Agriculture Industries
Environmental Testing Laboratories
Petrochemical Refineries and Oil & Gas Industry
Other Industries (Forensics and Metal & Mining Laboratories)
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
China
Japan
India
South Korea
Australia
Thailand
Latin America
Brazil
Argentina
Middle East and Africa (MEA)
South Africa
Saudi Arabia
UAE
Kuwait
b. The global laboratory information management system market size was estimated at USD 2.44 billion in 2024 and is expected to reach USD 2.63 billion in 2025.
b. The global laboratory information management system market is expected to grow at a compound annual growth rate of 6.22% from 2025 to 2030 to reach USD 3.56 billion by 2030.
b. The cloud-based segment dominated the global LIMS market and accounted for the largest revenue share of over 43.85% in 2024.
b. The services segment led the global laboratory information management system market and accounted for the largest revenue share of over 58.50% in 2024.
b. The life sciences segment dominated the global LIMS market and accounted for the largest revenue share of over 40.74% in 2024.
NEED A CUSTOM REPORT?
We offer custom report options, including stand-alone sections and country-level data. Special pricing is available for start-ups and universities.
Request CustomizationWe are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."